BRCA1 and ovarian carcinoma: We also show that BRCA1 germline mutations are associated with good prognosis for patients with ovarian cancer and OS was better for carriers of BRCA1 mutations (HR 0.14, 95 % CI: 0.032–0.650, p = 0.012) than for noncarriers.